Arbutus to Participate in Two Upcoming Investor Conferences
Article contentWARMINSTER, Pa., March 08, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop…